Imatinib-d8
For research use only. We do not sell to patients. Imatinib-d8 CAS No. : 1092942-82-9 Biological Activity:Imatinib D8 (STI571 D8) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[2]. Research Area:Cancer Targets:Autophagy|Bcr-Abl|c-Kit|PDGFR|SARS-CoV Related Small Molecules:AT9283;Bafetinib;Pivanex;Henatinib;SARS-CoV-2-IN-33;GRL-0496;SNIPER(ABL)-039;c-Kit-IN-5-1;Flumatinib mesylate;IHMT-TRK-284;Grazoprevir potassium salt;PDGFRα/FLT3-ITD-IN-2;SARS-CoV-2-IN-19;Molnupiravir;SARS-CoV-2 Mpro-IN-3;MM3122;Ketotifen fumarate;PP58;Chiauranib;SARS-CoV-2-IN-16;Zeteletinib […]